LexDanaLexDanabeta
Inventor

Holger Keim

Inventor
Irvine, CA, US

Overview

59→
Patents
2006–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 59 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
C07DHeterocyclic compounds26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium20%
C07KPeptides0%
G01NInvestigating or analysing materials by determining their chemical or physical properties0%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests0%
Y10TTechnical subjects covered by former us classification0%
PatentTitleYear
11,007,1932,4-pyrimidinediamine compounds and their uses202110,828,3012,4-pyrimidinediamine compounds and their uses202010,709,7032,4-pyrimidinediamine compounds and their uses202010,682,3502,4-pyrimidinediamine compounds and their uses202010,421,752Compositions and methods for inhibition of the JAK pathway201910,369,1482,4-pyrimidinediamine compounds and their uses201910,314,8402,4-pyrimidinediamine compounds and their uses201910,259,826Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds20199,913,842'2,4-pyrimidinediamine compounds and their uses'20189,751,893'Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds'20179,732,073'Compositions and methods for inhibition of the JAK pathway'20179,586,908'2,4-pyrimidinediamine compounds and their uses'20179,540,334'2,4-pyrimidinediamine compounds and their uses'20179,499,493'2,4-pyrimidinediamine compounds and their uses'20169,416,112'2,4-pyrimidinediamine compounds and their uses'20169,346,765'2,4-pyrimidinediamine compounds and their uses'20169,248,190'Compositions and methods for inhibition of the JAK pathway'20169,162,989'2,4-Pyrimidinediamine compounds and their uses'20159,133,133'2,4-pyridinediamine compounds and their uses'20159,040,550'2,4-pyrimidinediamine compounds and their uses'20159,018,204'2,4-pyrimidinediamine compounds and their uses'20158,853,397'2,4-pyrimidinediamine compounds and their uses'20148,835,430'2,4-pyrimidinediamine compounds and their uses'20148,822,685'2,4-pyrimidinediamine compounds and their uses'20148,815,848'Compositions and methods for inhibition of the JAK pathway'20148,557,806'Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds'20138,415,365'Compositions and methods for inhibition of the JAK pathway'20138,410,266'2,4-pyrimidinediamine compounds and their uses'20138,399,472'Compositions and methods for inhibition of the JAK pathway'20138,334,296'2,4-pyrimidinediamine compounds and their uses'20128,299,087'Compositions and methods for inhibition of the JAK pathway'20128,188,276'2,4-pyrimidinediamine compounds and their uses'20128,178,671'Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds'20128,158,621'Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds'20128,148,525'2,4-pyrimidinediamine compounds and their uses'20127,906,644'2,4-pyrimidinediamine compounds and their uses'20117,834,024'Compositions and methods for inhibition of the JAK pathway'20107,825,116'N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines'20107,820,819'2,4-pyrimidinediamine compounds and their uses'20107,812,029'Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds'20107,803,939'2,4-pyrimidinediamine compounds and their uses'20107,655,797'Intermediates for making 2,4-pyrimidinediamine compounds'20107,642,351'2,4-Pyrimidinediamine compounds and their uses'20107,589,200'5-Fluoro-4N-phenyl-4-pyrimidineamine compounds'20097,582,648'Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds'20097,560,466'Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds'20097,557,210'2,4-pyrimidinediamine compounds and their uses'20097,550,460'2,4-pyrimidinediamine compounds and their uses'20097,517,886'Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds'20097,498,435'2,4-pyrimidinediamine compounds and their uses'20097,485,724'2,4-pyrimidinediamine compounds and their uses'20097,452,879'Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds'20087,435,814'2,4-Pyrimidinediamine compounds and their uses'20087,332,484'2,4-pyrimidinediamine compounds and their uses'20087,329,671'2,4-pyrimidinediamine compounds and their uses'20087,329,672'2,4-pyrimidinediamine compounds and their uses'20087,189,582'Compositions and methods for detection of sirolimus'20077,122,542'Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds'20067,060,827'Intermediates useful for making 2,4-pyrimidinediamine compounds'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2021Patents assigned to RIGEL PHARMACEUTICALS INC (58)· patent assignee history
2006–2017Based in Menlo Park, CA, US· patent location history
2007–2013Based in Wyckoff, NJ, US· patent location history
2010–2020Based in Irvine, CA, US· patent location history
2010Based in Wycoff, NJ, US· patent location history
2012–2020Patents assigned to ARGADE ANKUSH (16)· patent assignee history
2012–2020Patents assigned to BHAMIDIPATI SOMASEKHAR (16)· patent assignee history
2012–2020Patents assigned to KEIM HOLGER (16)· patent assignee history
2012–2020Patents assigned to LI HUI (16)· patent assignee history
2016–2021Based in Newbury Park, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
RIGEL PHARMACEUTICALS INC582006–2021
ARGADE ANKUSH162012–2020
BHAMIDIPATI SOMASEKHAR162012–2020
KEIM HOLGERself162012–2020
LI HUI162012–2020
Locations
LocationPatentsSpan
Irvine, California, US232010–2020
Menlo Park, California, US232006–2017
Newbury Park, California, US82016–2021
Wyckoff, New Jersey, US42007–2013
Wycoff, New Jersey, US12010